AI-powered pathology is transforming cancer care

In May, Sundar Pichai, CEO of Google, discussed AI applications for digital pathology in his keynote speech to an audience of millions at Google's annual I/O event. Five weeks earlier, the FDA announced it had approved the first whole slide imaging system for primary diagnostic use in pathology. Both events point to the future of pathology and laboratory medicine: Software will soon dominate. Over the past 20 years, software has taken over the world. Retail was dominated by Amazon, Netflix put Blockbuster out of business, and Uber used software to take over the taxi industry.